AlphaYouRM
Congress trade
Rep. Roger Marshall (R-KS) sold $1K-$15K of Capricor Therapeutics, Inc. (CAPR) stock
Roger Marshall, U.S. Representative (R-KS), disclosed a sale of Capricor Therapeutics, Inc. (CAPR) stock worth $1K-$15K in a STOCK Act filing on Aug 6, 2018.
The trade happened on Jul 27, 2017, 375 days before it was made public.
CAPR has moved -31.2% since the trade date, from $13.00 to $8.95 (Oct 2, 2026 close).
- Traded
- Jul 27, 2017
- Disclosed
- Aug 6, 2018
- Filing delay
- 375 days
- Price since
- -31.2%
- Source
- STOCK Act disclosure
Other trades in this disclosure (60)
- BuyAEZS$1K-$15KAug 6, 2018
- SellAEZS$1K-$15KAug 6, 2018
- SellAMD$1K-$15KAug 6, 2018
- BuyAMD$1K-$15KAug 6, 2018
- BuyARCI$1K-$15KAug 6, 2018
- SellARCI$1K-$15KAug 6, 2018
- BuyATOS$1K-$15KAug 6, 2018
- SellBONT$1K-$15KAug 6, 2018
- SellCASY$1K-$15KAug 6, 2018
- BuyCASY$1K-$15KAug 6, 2018
- SellCASY$1K-$15KAug 6, 2018
- BuyCBAY$1K-$15KAug 6, 2018
- SellCBAY$1K-$15KAug 6, 2018
- BuyCLSN$1K-$15KAug 6, 2018
- SellCLSN$1K-$15KAug 6, 2018
- BuyCLSN$1K-$15KAug 6, 2018
- SellCLSN$1K-$15KAug 6, 2018
- BuyCMG$1K-$15KAug 6, 2018
- SellCMG$1K-$15KAug 6, 2018
- BuyCMG$1K-$15KAug 6, 2018
More CAPR insider and Congress trades
From a public STOCK Act disclosure, linked above. Not investment advice, and not a recommendation to buy or sell.